“showed a trend”

However, with the 5% and 50% cutoff values, the T-PD-L1 (+) group showed a trend of disadvantage in survival over the T-PD-L1 (−) group (p=0.12 and p=0.11).

Although survival differences among infiltration groups did not reach statistical significance, T-cell infiltrated patients showed a trend toward improved outcomes ( online supplemental figure 2B ; HR=0.31, p=0.12).

Although the HIGH group showed a trend toward a higher CI post-ROSC, the differences did not reach statistical significance ( p = 0.12).

2.7% of placebo (HR 0.61, 95% CI 0.38-0.99, P = 0.04), while nonfatal MI showed a trend toward reduction (2.9% vs. 3.9%, HR 0.74, 95% CI 0.51-1.08, P = 0.12).

Conversely, those with CTNNB1 mutations showed a trend toward longer OS (P=0.12) ( Figure 4B ).

combination therapy) showed a trend toward improved outcomes after combination therapy (HR: 0.21, 95% CI: 0.03–1.50, p=0.12), but that did not reach statistical significance.

(e) The ratio of open arm to total arm entries in the elevated plus maze showed a trend towards more open arm entries in J20 animals and a recovery of this in GluA2 G/G /J20 mice (Welch’s ANOVA W (3,29.15) = 2.12, p = 0.12; n’s : WT = 15, GluA2 G/G = 13, J20 = 16, GluA2 G/G /J20 = 14).

A comparison of Receptor-ITH between Grades 2 and 3 showed a trend toward reduced ITH with cancer progression ( p = 0.12; Fig. 2E , Supplementary Data 3 ).

CB patients also showed a trend toward higher 5 and 10 year regional control rates compared with SD patients (97.7% and 97.7% vs 97.1% and 82.9%, respectively; P = .12 for both) at 5 and 10 years, respectively.

No notable differences were observed, but BMI in males showed a trend of increasing with age (p=0.12).

reported significantly elevated post-exercise noradrenaline levels in the BFR group compared to controls ( p < 0.05), while growth hormone showed a trend toward elevation that did not reach statistical significance ( p = 0.12) [ 33 ].

Demographic Relationships Univariate testing showed that high wave amplitudes were more likely in females ( p < 0.001), for low body weights (linear regression, r = −0.46, p < 0.001) and when the blood Hb was low at baseline ( r = −0.48, p < 0.001), but they only showed a trend to decrease with age ( p = 0.12).

Correlation between EME and RT ( Figure 2 ) showed no strong association except for the 2 and 8 h time points postfeeding, although the 8 h time point showed a trend ( P = 0.12) in LR cows.

Interim OS data showed a trend towards benefit for both combination arms compared to CP alone (P=0.12 with CP + durvalumab versus CP; HR, 0.77; P=0.003 with CP + durvalumab + olaparib vs.

Multivariable analysis showed a trend toward decreased odds of an abnormal contrast swallow when a speech-language pathologist was present during the examination (OR =0.448, 95% CI: 0.165–1.215, P=0.12).

JAK1-selective inhibitor showed a trend for better retention rate compared to pan-JAK inhibitors ( p = 0.12; Figure 3 ).

Multivariate correlation analysis yielded no statistically significant results when comparing individual comorbidities to death (Figure 7 ) but showed a trend towards diabetes modestly decreasing survival (Pearson r=0.16; p=0.12).

As expected, the fronto-parietal network showed a trend of decreased connectivity with the dorsal attention network ( t (32) = −1.62, p = 0.12) and increased connectivity with the default mode network ( t (32) = 2.28, p = 0.03).

Specifically, 7 days following immunization, vehicle-treated control mice showed a trend toward a greater DNP-specific IgM response than that of SU5416-treated mice (p = 0.12, Fig. 6B ).

Although AMPCP treatment in the NI condition showed a trend toward increased LD area, this difference was not statistically significant ( p = 0.1203).

MYC breaks showed a trend for inferior EFS (HR 1.601, 95% CI 0.879–2.915, p = 0.1206) and statistically significantly reduced OS (HR 2.531, 95% CI 1.240–5.166, p = 0.0083; Fig. 1c, d ).

HLA-B*07 also showed a trend-level association (OR = 2.33, 95% CI [0.79, 6.50], p = 0.121, p adj = 0.642).

The extent of intraoperative decrease showed a trend towards a significant higher reduction in the on-pump group when compared to the OPCAB (26.1±11.6% (mean ± SD ) vs. 19.1±15.6%; p = 0.121).

On day 12, although the individual PGF 2 α and PGE 2 levels showed a trend of increase and decrease, respectively, these changes were not statistically significant compared with those in the control group (PGF 2α : 201.40 pg/mg, p = 0.121; PGE 2 : 459.20 pg/mg, p = 0.134).

Subgroup analysis of patients ≥60 years showed a trend toward improved 2-year OS with fludarabine/cyclophosphamide/total body irradiation (Flu/Cy/TBI) versus fludarabine/busulfan: 71% versus 53% (HR = 0.47, p = 0.121).